Search results
2 Top Growth Stocks That Could Soar This Spring
Motley Fool· 1 year agoIf you're looking for stocks that can make big moves in a short amount of time, the biotech industry has you covered. There are some drugmaker stocks out...
Could Regeneron Stock Help You Retire a Millionaire?
Motley Fool via Yahoo Finance· 5 months agoThere are many ways one could end up with $1 million or more by retirement. Putting enough money in a savings account or winning the lottery are among...
Takeda's treatment becomes first oral therapy for esophageal condition in US
Reuters via Yahoo News· 4 months agoThe U.S. health regulator's approval makes the therapy the first oral treatment for the condition,...
How Managing Eczema Became a Slam Dunk for WNBA Star Diana Taurasi
Healthline via AOL· 1 day agoWNBA legend Diana Taurasi (above) is sharing how she learned to manage painful eczema flair-ups....
Will Loss of REGEN-COV Sales Hurt Regeneron (REGN) in 2022?
Zacks via Yahoo Finance· 2 years agoBiotech giant Regeneron Pharmaceuticals REGN witnessed a massive surge in sales in 2021, driven by...
Sanofi (SNY) Q1 2023 Earnings Call Transcript
Motley Fool· 1 year agoImage source: The Motley Fool. Sanofi (NASDAQ: SNY) Q1 2023 Earnings Call Apr 27, 2023, 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers...
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 2 months agoThe phrase "the golden age of biotech" was somewhat popular a few years ago but now seems largely...
Diana Taurasi Is Down for One More Party
GQ via Yahoo Sports· 8 hours agoThe WNBA’s all-time leading scorer on her Olympic plans in Paris, feeling like a war veteran around women’s basketball’s new generation, and her journey...
The Zacks Analyst Blog Highlights Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – December 19, 2023 – Zacks.com announces the list of stocks...
This Market-Beating Stock Just Gave Investors More Reasons to Invest
Motley Fool· 8 months agoConsider the case of Regeneron (NASDAQ: REGN), a biotech company that has beaten the market in...